Literature DB >> 7308497

Mechanisms of action of calcium entry blockers.

T Godfraind.   

Abstract

This review is focused on experimental observations that permit conclusions about the mechanism of action of calcium entry blockers. It is shown that studies on the blockade of contraction (or relaxation) of depolarized smooth muscle must be confirmed by direct estimates of calcium fluxes. Superimposition of dose-inhibition curves of contraction and 45Ca entry are a prerequisite for allowing a drug to be regarded as a specific calcium entry blocker. Among the main characteristics of such drugs are their tissue selectivity and use dependency in depolarized preparations. It is shown that one of these (flunarizine) interacts with binding sites located in the plasma membrane possibly associated with the calcium channels. The physiological role of calcium and possible therapeutic uses of calcium entry blockers are also summarized.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308497

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  17 in total

Review 1.  Why are converting enzyme inhibitors vasodilators?

Authors:  P M Vanhoutte; W Auch-Schwelk; M L Biondi; R R Lorenz; V B Schini; M J Vidal
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

2.  Proceedings of the British Pharmacological Society, University of Cambridge, 6th-8th April, 1983. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

3.  Role of calcium in gamma interferon induction: inhibition by calcium entry blockers.

Authors:  F Dianzani; M R Capobianchi; J Facchini
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

4.  Anticonvulsant effects of some calcium entry blockers in DBA/2 mice.

Authors:  G B De Sarro; B S Meldrum; G Nisticó
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

5.  Inhibition of polar calcium movement and gravitropism in roots treated with auxin-transport inhibitors.

Authors:  J S Lee; T J Mulkey; M L Evans
Journal:  Planta       Date:  1984-05       Impact factor: 4.116

6.  An approach to differentiate between noradrenaline-elicited contractile processes in the rat isolated aorta.

Authors:  P Koch; B Wilffert; D Wilhelm; T Peters
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

7.  Direct inhibitory effects of some 'calcium-antagonists' and trifluoperazine on the contractile proteins in smooth muscle.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

8.  Effects of yohimbine, rauwolscine and corynanthine on contractions and calcium fluxes induced by depolarization and prostaglandin F2 alpha in rat aorta.

Authors:  T Godfraind; R C Miller; J Socrates Lima
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

9.  Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.

Authors:  J Timar; H Chopra; X Rong; J S Hatfield; S E Fligiel; J M Onoda; J D Taylor; K V Honn
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 10.  Calcium antagonists. Pharmacodynamic effects and mechanism of action.

Authors:  T T Zsotér; J G Church
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.